US 8188149
Use of R(+)-N-propargy1-1-aminoindan to treat or prevent hearing loss
granted A61KA61K31/135A61P
Quick answer
US patent 8188149 (Use of R(+)-N-propargy1-1-aminoindan to treat or prevent hearing loss) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue May 29 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/135, A61P, A61P27/16